CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 173 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $37,230,000 | -26.0% | 1,500,000 | -46.4% | 1.86% | -22.3% |
| Q4 2018 | $50,288,000 | -2.2% | 2,800,000 | +60.0% | 2.39% | +8.5% |
| Q3 2018 | $51,398,000 | +13.0% | 1,750,000 | +75.0% | 2.20% | +25.7% |
| Q2 2018 | $45,470,000 | +4.4% | 1,000,000 | +21.2% | 1.75% | -18.2% |
| Q1 2018 | $43,560,000 | +6.8% | 825,000 | +37.5% | 2.14% | +7.1% |
| Q4 2017 | $40,800,000 | +147.6% | 600,000 | +200.0% | 2.00% | +91.3% |
| Q3 2017 | $16,480,000 | – | 200,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |